ROCKWELL MEDICAL, INC.·4

Mar 16, 6:08 PM ET

Strobeck Mark 4

4 · ROCKWELL MEDICAL, INC. · Filed Mar 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Rockwell Medical CEO Mark Strobeck Withholds 7,333 Shares for Taxes

What Happened
Mark Strobeck, President, CEO and Director of Rockwell Medical, had 7,333 restricted stock unit (RSU) shares withheld to satisfy his estimated tax withholding obligation. The withholding was recorded at $0.90 per share, for a total value of $6,600. This is an administrative tax-withholding event on vesting, not an open-market sale or purchase.

Key Details

  • Transaction date: 2026-03-14; filed on Form 4 2026-03-16 (appears timely, within the usual two-business-day window).
  • Share amount withheld: 7,333 shares at $0.90 per share; total value $6,600.
  • Transaction code: F (payment of exercise price or tax liability / tax withholding).
  • Footnote: F1 — shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
  • Shares owned after transaction: not specified in the provided excerpt of the filing.

Context
Tax-withholding on RSU vesting is routine and reflects an administrative disposition of shares to satisfy taxes; it does not necessarily signal insider sentiment about the company. Unlike an open-market sale, withheld shares reduce the insider’s outstanding share count without a market transaction.

Insider Transaction Report

Form 4
Period: 2026-03-14
Strobeck Mark
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-03-14$0.90/sh7,333$6,600323,493 total
Footnotes (1)
  • [F1]These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
Signature
/s/ Megan Timmins, Attorney-in-fact for Mark Strobeck|2026-03-16

Documents

1 file
  • 4
    wk-form4_1773698920.xmlPrimary

    FORM 4